Bioavailability and Short-Term Tolerability of Alendronate in Glucocorticoid-Treated Children

2011 ◽  
Vol 33 (10) ◽  
pp. 1516-1523 ◽  
Author(s):  
Meranda Nakhla ◽  
Andrew E. Denker ◽  
James D. Connor ◽  
Thomas O. Carpenter ◽  
Philip D. Walson ◽  
...  
Keyword(s):  
Short Term ◽  
Term Tolerability

scholarly journals Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety

2011 ◽  
Vol 46 (7) ◽  
pp. 666-671 ◽  
Author(s):  
Margaret Rosenfeld ◽  
Stephanie Davis ◽  
Lyndia Brumback ◽  
Stephen Daniel ◽  
Ron Rowbotham ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Hypertonic Saline ◽  
Infants And Toddlers ◽  
Short Term ◽  
Term Tolerability

Optimization, in vitro–in vivo Evaluation, and Short-term Tolerability of Novel Levofloxacin-loaded PLGA Nanoparticle Formulation

2012 ◽  
Vol 101 (6) ◽  
pp. 2165-2176 ◽  
Author(s):  
Gaurav Kumar ◽  
Sadhna Sharma ◽  
Nusrat Shafiq ◽  
Gopal Krishan Khuller ◽  
Samir Malhotra
Keyword(s):  
Short Term ◽  
In Vivo Evaluation ◽  
Term Tolerability ◽  
Nanoparticle Formulation ◽  
Plga Nanoparticle

Treatment of Acute Mania

CNS Spectrums ◽  
2003 ◽  
Vol 8 (12) ◽  
pp. 917-928 ◽  
Author(s):  
Paul E. Holtzheimer ◽  
John F. Neumaier
Keyword(s):  
Clinical Practice ◽  
Side Effects ◽  
Drug Administration ◽  
Mood Stabilizers ◽  
Acute Mania ◽  
Treatment Resistant ◽  
Short Term ◽  
The Past ◽  
Term Tolerability

AbstractMood stabilizers have evolved considerably over the past decade. Lithium, divalproex, and olanzapine are currently Food and Drug Administration-approved for the treatment of acute mania. A number of new and traditional medications have also been tested and are commonly used in clinical practice. Several strategies for managing treatment-resistant mania have been suggested, but few have been rigorously tested. Emphases on rapid stabilization and fewer side effects have raised the bar for what is expected from mood stabilizers and the successful treatment of mania involves a delicate balance between swiftness, short-term tolerability, and long-term safety.

SHORT-TERM TOLERABILITY, SAFETY, AND PHARMACOKINETIC PROFILE OF ASENAPINE IN OLDER PATIENTS WITH PSYCHOSIS

2010 ◽  
Vol 117 (2-3) ◽  
pp. 263-264 ◽  
Author(s):  
Steven L. Dubovsky ◽  
Colleen Frobose ◽  
Phillip Phiri ◽  
John Panagides
Keyword(s):  
Older Patients ◽  
Pharmacokinetic Profile ◽  
Short Term ◽  
Term Tolerability
Sign in / Sign up

Export Citation Format

Share Document